3.2 Neonatal Hypoglycemia & Metabolic Problems

Neonatal Glucose Homeostasis

In utero, the fetus receives a continuous transplacental glucose supply. At birth this supply stops abruptly, and the newborn must mount a coordinated hormonal response — a surge in glucagon and catecholamines with a fall in insulin — to drive glycogenolysis and gluconeogenesis until regular feeding is established. Failure of this transition, or an underlying disease process, produces neonatal hypoglycemia, one of the most heavily tested newborn topics because the correct threshold is genuinely debated in the literature.

Defining the Threshold: AAP vs. PES

There is no single universal glucose number that defines neonatal hypoglycemia for every infant — the exam expects familiarity with two different operational thresholds:

A commonly used operational treatment target for at-risk or symptomatic infants in the first 24 hours is below 45 mg/dL (2.5 mmol/L).

At-Risk Infants Who Require Routine Screening

Only specific at-risk groups need protocol-driven glucose screening — a well term infant with no risk factors does not:

• Infant of a diabetic mother (IDM) — fetal hyperinsulinemia develops in response to maternal hyperglycemia; risk is highest in the first hours of life once the maternal glucose supply is cut off
• Small-for-gestational-age (SGA) infants — reduced glycogen stores
• Large-for-gestational-age (LGA) infants, even without maternal diabetes
• Late-preterm infants (34 to 36 weeks 6 days) — immature counter-regulatory response
• Infants with perinatal stress — asphyxia, sepsis, hypothermia, or significant respiratory distress

Screening protocol: check glucose within 30-60 minutes of the first feed, then per unit protocol every 3-6 hours for at least 24 hours, extended to 24-48 hours for SGA and late-preterm infants.

Clinical Signs

Hypoglycemia is frequently asymptomatic, which is exactly why at-risk infants are screened by protocol rather than tested only when symptomatic. When signs occur, they are nonspecific:

• Jitteriness, tremors, a high-pitched cry, irritability
• Poor feeding, lethargy, hypotonia
• Temperature instability, apnea, tachypnea
• Seizures in severe or prolonged hypoglycemia

Management

• Asymptomatic, glucose above threshold: continue routine feeding and rescreen per protocol
• Asymptomatic, mild-to-moderate hypoglycemia: enteral feed (breast milk or formula) with 40% dextrose gel massaged into the buccal mucosa — now a first-line adjunct shown to reduce NICU admission and mother-infant separation without affecting breastfeeding rates
• Symptomatic or severe hypoglycemia (below about 20-25 mg/dL): IV dextrose bolus of 200 mg/kg (2 mL/kg of 10% dextrose), followed by a continuous infusion at a glucose infusion rate (GIR) of 6-8 mg/kg/min, titrated upward if hypoglycemia persists
• Hypoglycemia persisting beyond the first week of life, or requiring a GIR above 12 mg/kg/min to maintain euglycemia, should prompt evaluation for persistent hyperinsulinism — drawing a critical sample (insulin, cortisol, growth hormone, beta-hydroxybutyrate) at the time of a documented low glucose, and considering diazoxide

Worked Example: Calculating the Glucose Infusion Rate

A 3-kg infant with symptomatic hypoglycemia is started on IV 10% dextrose (D10W) at 13.5 mL/hour. Using GIR (mg/kg/min) = (percent dextrose x 10 x mL/hour) divided by (60 x weight in kg): GIR = (10 x 10 x 13.5) / (60 x 3) = 1,350 / 180 = 7.5 mg/kg/min, squarely within the 6-8 mg/kg/min target range. If the infant remains hypoglycemic despite this rate, the GIR is increased in small steps (typically by 2 mg/kg/min) rather than simply raising the dextrose concentration, since concentrations above 12.5% dextrose require central venous access because of the risk of peripheral vein sclerosis.

Point-of-care caveat: bedside glucometer readings can run 10-15% lower than a laboratory glucose-oxidase sample, particularly at low values. Any critically low point-of-care result that will guide a major treatment decision should be confirmed with a laboratory sample, though treatment should never be delayed while awaiting confirmation in a symptomatic infant.

Other Neonatal Metabolic Problems

Hypocalcemia

• Early hypocalcemia (within 72 hours): seen with prematurity, IDM, and birth asphyxia — the abrupt loss of transplacental calcium combined with an immature parathyroid response. Total calcium below 8 mg/dL in term infants (below 7 mg/dL in preterm infants); ionized calcium below 4.4 mg/dL
• Late hypocalcemia (after 72 hours): classically caused by high-phosphate cow's-milk-based formula, or by hypoparathyroidism — think DiGeorge syndrome (22q11.2 deletion) in an infant with hypocalcemic seizures plus a conotruncal cardiac defect
• Signs: jitteriness, seizures, a prolonged QT interval; treatment is IV calcium gluconate 10%, given slowly with cardiac monitoring since extravasation causes tissue necrosis

Transient Tachypnea of the Newborn (TTN)

Caused by delayed clearance of fetal lung fluid. Risk factors include cesarean delivery without labor, macrosomia, and maternal diabetes. TTN presents within hours of birth with tachypnea and mild retractions; chest X-ray shows perihilar streaking and fluid in the interlobar fissures. It is self-limited, typically resolving within 24-72 hours with supportive oxygen — distinguish it from respiratory distress syndrome (preterm infant, ground-glass opacities, surfactant deficiency) and from sepsis-related respiratory distress.

Polycythemia

Defined as a venous hematocrit above 65%. Associated with IDM, SGA, delayed cord clamping, and the recipient twin in twin-twin transfusion syndrome. Hyperviscosity causes microvascular sludging, which is itself a cause of hypoglycemia through increased red-cell glucose consumption, along with plethora, respiratory distress, and jitteriness. Symptomatic infants with a hematocrit above 65%, or asymptomatic infants above 75%, may need a partial exchange transfusion; mild cases are managed with hydration.